21^st World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry June 16-17, 2021 London, UK

Dr. Adam Le Gresley obtained his PhD from the University of Surrey, working under Professor Nikolai Kuhnert on the synthesis of Calix[4]arene derivatives for dynamic combinatorial libraries. He undertook his postdoctoral work as an NIH Research Fellow at Drexel College of Medicine in the USA, working on the synthesis and evaluation of "caged" compounds for probing biological pathways. Since joining Kingston University in 2009, He have established a research group in organic and analytical chemistry, funded by industrial sponsors such as GlaxoSmithKline and LGC Ltd, working on the design and synthesis of fluorogenic compounds for problem pathogen detection and method development for NMR metabolomics/2D qNMR for complex mixture analysis and metrology. He have collaborations with institutions in Germany, Australia and the USA. He have 20 publications in peer-reviewed journals and 2 patents.

Metrology and G-quadruplex ligand development for cancer treatment

Pillhun son is broadly experienced in working with diverse teams internally and externally in global environments. Fearless in diving into new tasks and passionate in facing challenges and resolving obstacles. Powerful aptitude in problem solving and efficient in leading large teams in goal-oriented projects. Constant research and continuous learning of related topics, competition, and applicable successful models. Pill Hun Son earned his PhD from Texas Tech University in Organic and Computational Chemistry and then moved on to work on Material Science and Physical Chemistry during his Postdoc. He has worked on several database building and information solution initiatives for CAS, including, CASREACT (CAS’s premier reaction database) and the all new Formulations information solution (set to launch mid 2017). Most recently, Pill also achieved a MS in Information Systems from Northwestern University.

Material Science and Physical Chemsitry

I have diverse leadership experience as a health services professional with significant accomplishments in all aspects of pharmacovigilance, clinical development, medical affairs, regulatory affairs, primary health care, project management & international health programs. I have vast experience of working in diverse therapeutic areas including rare diseases, novel preventive & therapeutic vaccines, monoclonal antibodies, cardiovascular, oncology, neurology, nosocomial diseases, generic and OTC medicines. I am currently working as Disease Area Cluster Lead for Biosimilars & Drug Delivery Devices at Pfizer. Currently Pfizer has the largest biosimilars portfolio in the industry that includes projects on Inflammation, Oncology, Hematology, ophthalmology etc. My past experience includes working as Associate vice president PV and Therapeutic Area Head (Rare Diseases) for Sanofi Genzyme, working as Senior Director & Director for vaccines PV at Sanofi Pasteur, working as Medical Consultant for Apotex Inc Canada. Prior to joining industry I had worked as Joint Executive Director for Pakistan Institute of Medical Sciences (PIMS), Registrar of the Post graduate medical institute PIMS and as Deputy Director General, Ministry of Health Pakistan. I have also worked on various primary healthcare, public health, health planning & development programs as well World food, UNICEF, WHO & JICA assisted programs on drug safety, emergency preparedness, and primary healthcare.

Pharmacovigilance, Drug safety

Dr. Tirotta has been an active member of Miami Children’s Hospital medical staff since 1991, practicing with the Department of Anesthesiology; he has served as the Director of Cardiac Anesthesia since 2002. He has served as Chief of the Department of Anesthesia since July 2017. He also has a clinical appointment with the Department of Anesthesiology at The University of Miami School of Medicine Dr. Tirotta received his BA from Cornell University in 1982 and his MD from New York University School of Medicine in 1986. He also received an MBA degree from Columbia University in 1999. Dr. Tirotta completed his internship in Internal Medicine at SUNY at Stony Brook in 1987. He completed his residency training in anesthesiology at the University of Miami/Jackson Memorial Hospital in 1990; he sub-specialized in pediatric and cardiovascular anesthesia, including heart transplantation. In 1994, Dr. Tirotta created and produced the widely acclaimed pre-operative educational video titled, “A Hospital Trip with Dr. Bip”. This program, narrated by the endearing animated character Dr. Bip, explains to young children what to expect when they go to the hospital for surgery. It also includes coloring books and stickers. This program was exhibited at numerous national medical conventions and has sold thousands of copies all over the English-speaking world. Dr. Tirotta is a member of numerous professional societies and has served on a number of hospital committees, including the Heart Program Executive Committee. He previously served as the Co-Chair of the Miami Children’s Hospital Physician Hospital Organization. He is also responsible for giving numerous medical lectures nationally and internationally and is actively engaged in clinical research. He has been the Principal Investigator on a number of clinical drug/device trials, including on the ONQ Pain Buster, the muscle relaxant Zemuron, the procoagulant RiaSTAP, the Cardiotronic NICOM device and the ClearLine.

Cardiovascular anesthesia including heart transplantation.